Skip to content
The El Paso

A new ADHD drug just got FDA approval. Here's what makes it different.

A new ADHD drug just got FDA approval. Here's what makes it different.
Photo: KVIA ABC-7 · view original

The Food and Drug Administration (FDA) just approved Simtriyo (centanafadine), a new norepinephrine, dopamine, serotonin reuptake inhibitor (NDSRI) and central nervous system (CNS) stimulant. The medication treats ADHD in adults, teens, and children ages 6 and up weighing at least 44 pounds. Most...

Sources and story details